Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jul;47(7):1815-1825.
doi: 10.1007/s40618-023-02287-x. Epub 2024 Jan 31.

A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas

Affiliations
Case Reports

A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas

C Smirne et al. J Endocrinol Invest. 2024 Jul.

Abstract

Purpose: Multiple endocrine neoplasia type 1 (MEN1) is a hereditary endocrine syndrome caused by pathogenic variants in MEN1 tumor suppressor gene. Diagnosis is commonly based on clinical criteria and confirmed by genetic testing. The objective of the present study was to report on a MEN1 case characterized by multiple pancreatic glucagonomas, with particular concern on the possible predisposing genetic defects.

Methods: While conducting an extensive review of the most recent scientific evidence on the unusual glucagonoma familial forms, we analyzed the MEN1 gene in a 35-year-old female with MEN1, as well as her son and daughter, using Sanger and next-generation sequencing (NGS) approaches. We additionally explored the functional and structural consequences of the identified variant using in silico analyses.

Results: NGS did not show any known pathogenic variant in the tested regions. However, a new non-conservative variant in exon 4 of MEN1 gene was found in heterozygosity in the patient and in her daughter, resulting in an amino acid substitution from hydrophobic cysteine to hydrophilic arginine at c.703T > C, p.(Cys235Arg). This variant is absent from populations databases and was never reported in full papers: its characteristics, together with the high specificity of the patient's clinical phenotype, pointed toward a possible causative role.

Conclusion: Our findings confirm the need for careful genetic analysis of patients with MEN1 and establish a likely pathogenic role for the new p.(Cys235Arg) variant, at least in the rare subset of MEN1 associated with glucagonomas.

Keywords: Adrenal gland adenoma; Familiar; Necrolytic migratory erythema; Neuroendocrine pancreatic tumor; Next-generation sequencing; Primary hyperparathyroidism.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Timeline with relevant data from the clinical history
Fig. 2
Fig. 2
Reverse and forward Sanger sequencing, confirming on a second DNA extraction from peripheral blood the c.703T > C nucleotide substitution (indicated by the arrow) in MEN1 exon 4 (NM_000244.3) identified by next-generation sequencing
Fig. 3
Fig. 3
Sequence alignment of menin protein across 12 species (human amino acids from 224 to 246). Cysteine 235 is within the red rectangle
Fig. 4
Fig. 4
Analysis of the structural impact of the missense variant recognizes for cysteine 235 of menin (sequence browser: O00255-1) highest buried and hydrophobicity indices suggesting a deleterious effect for p.Cys235Arg substitution (Missense3D)
Fig. 5
Fig. 5
Crystallographic structure of the menin protein showing an "internal" (buried) position for the hydrophobic cysteine 235 and a high score of intolerability toward any amino acid substitution in this protein position with particular regard to hydrophilic and charged residues such as a basic arginine. The higher and red the bars are, the more the amino acid substitution is predicted not tolerated (Missense3D)
Fig. 6
Fig. 6
Steric clash analysis of the menin protein with arginine at position 235, instead of cysteine, suggests a high rate of clashes that means bad side-chain placement, or possibly an incorrect backbone in the region (Phyre2)

Similar articles

Cited by

References

    1. Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) J Clin Endocrinol Metab. 2012;97:2990–3011. doi: 10.1210/jc.2012-1230. - DOI - PubMed
    1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658–5671. doi: 10.1210/jcem.86.12.8070. - DOI - PubMed
    1. Febrero B, Segura P, Ruiz-Manzanera JJ, et al. Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: do they have a relationship with the prognosis of these patients? J Endocrinol Investig. 2021;44:1327–1330. doi: 10.1007/s40618-020-01414-2. - DOI - PubMed
    1. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404–407. doi: 10.1126/science.276.5311.404. - DOI - PubMed
    1. Rizzoli R, Green J, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia Type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med. 1985;78:467–474. doi: 10.1016/0002-9343(85)90340-7. - DOI - PubMed

Publication types

Substances